Medtronic to Pay More Than $1 Billion to End Heart Valve Litigation

, The Recorder


The deal with Edwards Lifesciences nullifies two large jury awards and the threat of an injunction against potentially lifesaving technology.

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202656148229

Thank you!

This article's comments will be reviewed.